Cetylpyridinium chloride: Difference between revisions
Rabin Bista (talk | contribs) No edit summary |
Rabin Bista (talk | contribs) No edit summary |
||
Line 188: | Line 188: | ||
| ChEBI_Ref = {{ebicite|correct|EBI}} | | ChEBI_Ref = {{ebicite|correct|EBI}} | ||
| ChEBI = 32915 | | ChEBI = 32915 | ||
| SMILES = | | SMILES = Cl-.n+1(ccccc1)CCCCCCCCCCCCCCCC | ||
}} | }} | ||
Revision as of 13:17, 21 April 2015
{{DrugProjectFormSinglePage |authorTag=Rabin Bista, M.B.B.S. [1] |OTC=Yes |genericName=Cetylpyridinium chloride |aOrAn=a |drugClass=antiseptic |indicationType=treatment |indication=gingivitis |adverseReactions=staining of the teeth and tongue
|blackBoxWarningTitle=ConditionName: |blackBoxWarningBody=ConditionName:
- Content
|fdaLIADAdult=====Indications====
helps control plaque that leads to gingivitis
Dosage
|offLabelAdultGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Cetylpyridinium chloride in adult patients.
|offLabelAdultNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Cetylpyridinium chloride in adult patients.
|fdaLIADPed=====Indications====
helps control plaque that leads to gingivitis
Dosage
|offLabelPedGuideSupport=There is limited information regarding Off-Label Guideline-Supported Use of Cetylpyridinium chloride in pediatric patients.
|offLabelPedNoGuideSupport=There is limited information regarding Off-Label Non–Guideline-Supported Use of Cetylpyridinium chloride in pediatric patients.
|contraindications= |warnings=Keep out of reach of children under 6 years of age.
If more than used for rinsing is accidentally swallowed, get medical help or contact a Poison Control Center right away.
Stop use and ask a dentist if
gingivitis, bleeding, or redness persists for more than 2 weeks you have painful or swollen gums, pus from the gum line, loose teeth, or increasing spacing between the teeth These may be signs or symptoms of periodontitis, a serious form of gum disease.
|clinicalTrials=There is limited information regarding Clinical Trial Experience of Cetylpyridinium chloride in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
|postmarketing=staining of the teeth and tongue |drugInteractions= |useInPregnancyFDA=* Pregnancy Category |useInPregnancyAUS=* Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Cetylpyridinium chloride in women who are pregnant. |useInLaborDelivery=There is no FDA guidance on use of Cetylpyridinium chloride during labor and delivery. |useInNursing=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to nursing mothers. |useInPed=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to pediatric patients. |useInGeri=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to geriatric patients. |useInGender=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to specific gender populations. |useInRace=There is no FDA guidance on the use of Cetylpyridinium chloride with respect to specific racial populations. |useInRenalImpair=There is no FDA guidance on the use of Cetylpyridinium chloride in patients with renal impairment. |useInHepaticImpair=There is no FDA guidance on the use of Cetylpyridinium chloride in patients with hepatic impairment. |useInReproPotential=There is no FDA guidance on the use of Cetylpyridinium chloride in women of reproductive potentials and males. |useInImmunocomp=There is no FDA guidance one the use of Cetylpyridinium chloride in patients who are immunocompromised.
|administration=* Oral |monitoring=There is limited information regarding Monitoring of Cetylpyridinium chloride in the drug label.
|IVCompat=There is limited information regarding IV Compatibility of Cetylpyridinium chloride in the drug label.
|overdose=There is limited information regarding Overdose of Cetylpyridinium chloride in the drug label.
|drugBox=
Template:Chembox header2 | Cetylpyridinium chloride | |
---|---|
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
UNII | |
| |
| |
Template:Chembox header2 | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
{{#subobject:
|Page Name=Cetylpyridinium chloride |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Cetylpyridinium chloride |Label Name=Cetylpyridinium chloride11.png
}}
{{#subobject:
|Label Page=Cetylpyridinium chloride |Label Name=Cetylpyridinium chloride11.png
}}